| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0001 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.002 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |